Transient expansion of vestibular schwannoma following stereotactic radiosurgery

被引:121
|
作者
Nagano, Osamu [1 ]
Higuchi, Yoshinori
Serizawa, Toru [3 ]
Ono, Junichi [2 ]
Matsuda, Shinji [4 ]
Yamakami, Iwao
Saeki, Naokatsu
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuou Ku, Chiba 2600856, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan
[3] Chiba Cardiovasc Ctr, Gamma Knife House, Ichihara, Chiba, Japan
[4] Chiba Cardiovasc Ctr, Dept Neurol, Ichihara, Chiba, Japan
关键词
facial nerve function; Gamma Knife surgery; stereotactic radiosurgery; transient tumor expansion; trigeminal nerve dysesthesia; vestibular schwannoma;
D O I
10.3171/JNS/2008/109/11/0811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after stereotactic radiosurgery. Methods. One hundred Consecutive patients with unilateral VS treated with Gamma Knife Surgery (GKS) at Chiba Cardiovascular Center between 1998 and 2006 were analyzed in this study. For each lesion the Gd-enhanced volume was measured serially every 3 months in the 1st year, then every 6 months thereafter, using volumetric software. The frequency and degree of transient tumor expansion were documented and possible prognostic factors were analyzed. Concurrently, neurological deterioration involving trigeminal, facial, and cochlear nerve functions were also assessed. Results. The mean observation period was 65 months (range 25-100 months). There were 32 men and 68 women whose mean age was 59.1 years (range 29-80 years). Tumor volumes at GKS averaged 2.7 cm(3) (range 0.1-13.2 C 113), and the lesions were irradiated at the mean 52.2% isodose line for the tumor margin (range 50-67%), with a mean dose of 12.2 Gy (range 10.5-13 Gy) at the periphery. The tumor Volume was increased by 23% at 3 months and 27% at 6 months. Tumors shrank to their initial size over a mean period of 12 months. The maximum volume increase was < 10% (no significant increase) in 26 patients, 10-30% in 23, 30-50% in 22, 50-100% in 16, and > 100% in 13. The peak tumor expansion averaged 47% (range 0-613%). A high-dose (>= 3.5 Gy/min) treatment appears to be the greatest risk factor for transient tumor expansion, although the difference did not reach statistical significance. Transient facial palsy and facial dysesthesia correlated strongly with tumor expansion, but only half of the hearing loss was coincident with this phenomenon. Conclusions. Transient expansion of VSs after GKS was found to be much more frequent than previously reported, strongly Suggesting a correlation with deterioration of facial and trigeminal nerve functions.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 50 条
  • [31] The Tethered Effect of Vestibular Schwannoma Tumor Shrinkage Following Stereotactic Radiosurgery in Secondary Trigeminal Neuralgia
    Izumi, Masaki
    Higuchi, Yoshinori
    Yakufujiang, Maidinamu
    Motoshima, Takayuki
    Horiguchi, Kentaro
    Aoyagi, Kyoko
    Nagano, Osamu
    Serizawa, Toru
    Iwadate, Yasuo
    Yamakami, Iwao
    WORLD NEUROSURGERY, 2019, 123 : 136 - 141
  • [32] Radiation-Induced Sarcoma in a Large Vestibular Schwannoma Following Stereotactic Radiosurgery: Case Report
    Schmitt, William R.
    Carlson, Matthew L.
    Giannini, Caterina
    Driscoll, Colin L. W.
    Link, Michael J.
    NEUROSURGERY, 2011, 68 (03) : E840 - E846
  • [33] Evaluation of Tumor Expansion Following 3-Fraction Stereotactic Radiosurgery for Vestibular Schwannomas
    Shah, J. L.
    Shaffer, J. L.
    Gibbs, I. C.
    Chang, S. D.
    Harsh, G. R.
    Choi, C. Y.
    Hanlon, A.
    Soltys, S. G.
    Hanlon, A.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S263 - S263
  • [34] Repeat single-fraction stereotactic radiosurgery for recurrent vestibular schwannoma
    Rapp, Cooper T.
    Amdur, Robert J.
    Bova, Frank J.
    Foote, Kelly D.
    Friedman, William A.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (04) : 655 - 658
  • [35] Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?
    Linskey, Mark E.
    JOURNAL OF NEUROSURGERY, 2008, 109 : 129 - 136
  • [36] Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery
    Berger, Assaf
    Alzate, Juan Diego
    Bernstein, Kenneth
    Mullen, Reed
    McMenomey, Sean
    Jethanemest, Daniel
    Friedmann, David R.
    Smouha, Eric
    Sulman, Erik P.
    Silverman, Joshua S.
    Roland, J. Thomas
    Golfinos, John G.
    Kondziolka, Douglas
    NEUROSURGERY, 2022, 91 (04) : 648 - 657
  • [37] High-grade glioma after stereotactic radiosurgery for vestibular schwannoma
    Aran-Echabe, Eduardo
    Cascallar Caneda, Luis
    Lobato Busto, Ramon
    Reyes Santias, Rosa Maria
    Varela Pazo, Ana
    Gelabert-Gonzalez, Miguel
    NEUROCIRUGIA, 2016, 27 (01): : 33 - 37
  • [38] Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery
    Berger, Assaf
    AlzateRamirez, Juan
    Bernstein, Kenneth
    Mullen, Reed
    McMenomey, Sean
    Jethanemest, Daniel
    Friedmann, David R.
    Smouha, Eric
    Sulman, Erik P.
    Silverman, Joshua S.
    Roland, J. Thomas
    Golfinos, John G.
    Kondziolka, Douglas
    NEUROSURGERY, 2023, 69 : 136 - 136
  • [39] Stereotactic radiosurgery in the management of vestibular schwannoma:a single-institution experience
    Silva, C.
    Amorim, M.
    Costa, M. A.
    Fonseca, G.
    Fardilha, C.
    Gagean, J.
    Simoes, S.
    Ponte, F.
    Campos, G.
    Seixas, C.
    Rodrigues, F.
    Costa, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S966 - S966
  • [40] Stereotactic fractionated radiotherapy and LINAC-Radiosurgery in the treatment of vestibular schwannoma
    Ladar, C
    Grosu, A
    Oestreicher, E
    Müller, A
    Arnold, A
    Molls, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S11 - S11